| Augmented backward elimination: a pragmatic and purposeful way to develop statistical models D Dunkler, M Plischke, K Leffondré, G Heinze PloS one 9 (11), e113677, 2014 | 207 | 2014 |
| Renal elimination of sclerostin increases with declining kidney function D Cejka, R Marculescu, N Kozakowski, M Plischke, T Reiter, A Gessl, ... The Journal of Clinical Endocrinology & Metabolism 99 (1), 248-255, 2014 | 166 | 2014 |
| PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression M Kohl, M Plischke, K Leffondré, G Heinze Computer methods and programs in biomedicine 118 (2), 218-233, 2015 | 138 | 2015 |
| Inorganic phosphate and FGF‐23 predict outcome in stable systolic heart failure M Plischke, S Neuhold, C Adlbrecht, B Bielesz, S Shayganfar, ... European journal of clinical investigation 42 (6), 649-656, 2012 | 92 | 2012 |
| Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score G Goliasch, ME Kleber, B Richter, M Plischke, M Hoke, A Haschemi, ... European heart journal 33 (18), 2282-2289, 2012 | 70 | 2012 |
| Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized … M Gaggl, D Cejka, M Plischke, G Heinze, M Fraunschiel, A Schmidt, ... Trials 14, 1-9, 2013 | 48 | 2013 |
| Urine osmolarity and risk of dialysis initiation in a chronic kidney disease cohort–a possible titration target? M Plischke, M Kohl, L Bankir, S Shayganfar, A Handisurya, G Heinze, ... PloS one 9 (3), e93226, 2014 | 45 | 2014 |
| Renal function in heart failure: a disparity between estimating function and predicting mortality risk M Plischke, S Neuhold, M Kohl, G Heinze, G Sunder‐Plassmann, ... European journal of heart failure 15 (7), 763-770, 2013 | 28 | 2013 |
| Clinical evaluation of two novel biointact PTH (1–84) assays in hemodialysis patients M Hecking, A Kainz, B Bielesz, M Plischke, G Beilhack, WH Hörl, ... Clinical biochemistry 45 (18), 1645-1651, 2012 | 28 | 2012 |
| Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients BO Bielesz, M Hecking, M Plischke, D Cejka, H Kieweg, M Haas, ... Clinical Biochemistry 47 (13-14), 1316-1319, 2014 | 14 | 2014 |
| The effect of ABCB1 polymorphisms on serial tacrolimus concentrations in stable Austrian long-term kidney transplant recipients M Riegersperger, M Plischke, C Steinhauser, A Jallitsch-Halper, ... Clinical laboratory 62 (10), 1965-1972, 2016 | 12 | 2016 |
| EFFECT OF CONVERSION FROM CYCLOSPORINE A TO TACROLIMUS ON ENDOTHELIAL PROGENITOR CELLS IN STABLE LONG-TERM KIDNEY TRANSPLANT RECIPIENTS. A RANDOMIZED CONTROLLED TRIAL M Riegersperger, M Plischke, S Steiner-Böker, D Seidinger, ... Nephrology Dialysis Transplantation 27 (suppl 2), ii525-ii536, 2012 | 11 | 2012 |
| Knowledge-based tacrolimus therapy for kidney transplant patients W Seeling, M Plischke, C Schuh Quality of Life through Quality of Information, 310-314, 2012 | 10 | 2012 |
| Pretransplant risk stratification for early survival of renal allograft recipients Ž Kikić, H Herkner, G Sengölge, N Kozakowski, G Bartel, M Plischke European Journal of Clinical Investigation 44 (2), 168-175, 2014 | 9 | 2014 |
| Late conversion of kidney transplant recipients from ciclosporin to tacrolimus improves graft function: results from a randomized controlled trial M Plischke, M Riegersperger, D Dunkler, G Heinze, Ž Kikić, ... Plos one 10 (8), e0135674, 2015 | 7 | 2015 |
| Urine osmolarity and risk of dialysis initiation in a CKD cohort L Bankir, M Plischke, N Bouby, M Haas Annals of Nutrition and Metabolism 66 (Suppl. 3), 14-17, 2015 | 7 | 2015 |
| A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 … M Riegersperger, M Plischke, A Jallitsch-Halper, C Steinhauser, ... Plos one 14 (7), e0218709, 2019 | 2 | 2019 |
| Knowledge-based immunosuppressive therapy for kidney transplant patients–from theoretical model to clinical integration W Seeling, M Plischke, JS de Bruin, C Schuh MEDINFO 2015: eHealth-enabled Health, 1119-1119, 2015 | 2 | 2015 |
| Research update for articles published in EJCI in 2012 RPF Dullaart, NM Al‐Daghri, M Ashina, A Bouzas‐Mosquera, ND Brunetti, ... European Journal of Clinical Investigation 44 (10), 1010-1023, 2014 | 1 | 2014 |
| CLINICAL EVALUATION OF NOVEL PTH(1-84) BIOINTACT ASSAYS IN HEMODIALYSIS PATIENTS M Hecking, A Kainz, B Bielesz, M Plischke, G Beilhack, WH Hoerl, ... Nephrology Dialysis Transplantation 27 (suppl 2), ii492-ii510, 2012 | 1* | 2012 |
Georg HeinzeBiostatistician, Medical University of ViennaGeverifieerd e-mailadres voor meduniwien.ac.at
